Copyright Reports & Markets. All rights reserved.

Global Semi-Solid Formulations Drug Delivery Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Semi-Solid Formulations Drug Delivery Market Size 2017-2028
    • 2.1.2 Semi-Solid Formulations Drug Delivery Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Semi-Solid Formulations Drug Delivery Segment by Type
    • 2.2.1 Creams
    • 2.2.2 Ointments
    • 2.2.3 Lotions
    • 2.2.4 Gel
    • 2.2.5 Pastes
  • 2.3 Semi-Solid Formulations Drug Delivery Market Size by Type
    • 2.3.1 Semi-Solid Formulations Drug Delivery Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Semi-Solid Formulations Drug Delivery Market Size Market Share by Type (2017-2022)
  • 2.4 Semi-Solid Formulations Drug Delivery Segment by Application
    • 2.4.1 Home Care Settings
    • 2.4.2 Hospitals & Clinics
    • 2.4.3 Burn Centers
    • 2.4.4 Other Facilities
  • 2.5 Semi-Solid Formulations Drug Delivery Market Size by Application
    • 2.5.1 Semi-Solid Formulations Drug Delivery Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Semi-Solid Formulations Drug Delivery Market Size Market Share by Application (2017-2022)

3 Semi-Solid Formulations Drug Delivery Market Size by Player

  • 3.1 Semi-Solid Formulations Drug Delivery Market Size Market Share by Players
    • 3.1.1 Global Semi-Solid Formulations Drug Delivery Revenue by Players (2020-2022)
    • 3.1.2 Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Players (2020-2022)
  • 3.2 Global Semi-Solid Formulations Drug Delivery Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Semi-Solid Formulations Drug Delivery by Regions

  • 4.1 Semi-Solid Formulations Drug Delivery Market Size by Regions (2017-2022)
  • 4.2 Americas Semi-Solid Formulations Drug Delivery Market Size Growth (2017-2022)
  • 4.3 APAC Semi-Solid Formulations Drug Delivery Market Size Growth (2017-2022)
  • 4.4 Europe Semi-Solid Formulations Drug Delivery Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Semi-Solid Formulations Drug Delivery Market Size by Country (2017-2022)
  • 5.2 Americas Semi-Solid Formulations Drug Delivery Market Size by Type (2017-2022)
  • 5.3 Americas Semi-Solid Formulations Drug Delivery Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Semi-Solid Formulations Drug Delivery Market Size by Region (2017-2022)
  • 6.2 APAC Semi-Solid Formulations Drug Delivery Market Size by Type (2017-2022)
  • 6.3 APAC Semi-Solid Formulations Drug Delivery Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Semi-Solid Formulations Drug Delivery by Country (2017-2022)
  • 7.2 Europe Semi-Solid Formulations Drug Delivery Market Size by Type (2017-2022)
  • 7.3 Europe Semi-Solid Formulations Drug Delivery Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Semi-Solid Formulations Drug Delivery by Region (2017-2022)
  • 8.2 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Semi-Solid Formulations Drug Delivery Market Forecast

  • 10.1 Global Semi-Solid Formulations Drug Delivery Forecast by Regions (2023-2028)
    • 10.1.1 Global Semi-Solid Formulations Drug Delivery Forecast by Regions (2023-2028)
    • 10.1.2 Americas Semi-Solid Formulations Drug Delivery Forecast
    • 10.1.3 APAC Semi-Solid Formulations Drug Delivery Forecast
    • 10.1.4 Europe Semi-Solid Formulations Drug Delivery Forecast
    • 10.1.5 Middle East & Africa Semi-Solid Formulations Drug Delivery Forecast
  • 10.2 Americas Semi-Solid Formulations Drug Delivery Forecast by Country (2023-2028)
    • 10.2.1 United States Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.2.2 Canada Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.2.3 Mexico Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.2.4 Brazil Semi-Solid Formulations Drug Delivery Market Forecast
  • 10.3 APAC Semi-Solid Formulations Drug Delivery Forecast by Region (2023-2028)
    • 10.3.1 China Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.3.2 Japan Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.3.3 Korea Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.3.4 Southeast Asia Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.3.5 India Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.3.6 Australia Semi-Solid Formulations Drug Delivery Market Forecast
  • 10.4 Europe Semi-Solid Formulations Drug Delivery Forecast by Country (2023-2028)
    • 10.4.1 Germany Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.4.2 France Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.4.3 UK Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.4.4 Italy Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.4.5 Russia Semi-Solid Formulations Drug Delivery Market Forecast
  • 10.5 Middle East & Africa Semi-Solid Formulations Drug Delivery Forecast by Region (2023-2028)
    • 10.5.1 Egypt Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.5.2 South Africa Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.5.3 Israel Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.5.4 Turkey Semi-Solid Formulations Drug Delivery Market Forecast
    • 10.5.5 GCC Countries Semi-Solid Formulations Drug Delivery Market Forecast
  • 10.6 Global Semi-Solid Formulations Drug Delivery Forecast by Type (2023-2028)
  • 10.7 Global Semi-Solid Formulations Drug Delivery Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Glenmark Pharmaceuticals
    • 11.1.1 Glenmark Pharmaceuticals Company Information
    • 11.1.2 Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Product Offered
    • 11.1.3 Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Glenmark Pharmaceuticals Main Business Overview
    • 11.1.5 Glenmark Pharmaceuticals Latest Developments
  • 11.2 Galderma
    • 11.2.1 Galderma Company Information
    • 11.2.2 Galderma Semi-Solid Formulations Drug Delivery Product Offered
    • 11.2.3 Galderma Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Galderma Main Business Overview
    • 11.2.5 Galderma Latest Developments
  • 11.3 Johnson & Johnson Private
    • 11.3.1 Johnson & Johnson Private Company Information
    • 11.3.2 Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Product Offered
    • 11.3.3 Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Johnson & Johnson Private Main Business Overview
    • 11.3.5 Johnson & Johnson Private Latest Developments
  • 11.4 GlaxoSmithKline
    • 11.4.1 GlaxoSmithKline Company Information
    • 11.4.2 GlaxoSmithKline Semi-Solid Formulations Drug Delivery Product Offered
    • 11.4.3 GlaxoSmithKline Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 GlaxoSmithKline Main Business Overview
    • 11.4.5 GlaxoSmithKline Latest Developments
  • 11.5 Bausch Health Companies
    • 11.5.1 Bausch Health Companies Company Information
    • 11.5.2 Bausch Health Companies Semi-Solid Formulations Drug Delivery Product Offered
    • 11.5.3 Bausch Health Companies Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Bausch Health Companies Main Business Overview
    • 11.5.5 Bausch Health Companies Latest Developments
  • 11.6 Hisamitsu Pharmaceuticals
    • 11.6.1 Hisamitsu Pharmaceuticals Company Information
    • 11.6.2 Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Product Offered
    • 11.6.3 Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Hisamitsu Pharmaceuticals Main Business Overview
    • 11.6.5 Hisamitsu Pharmaceuticals Latest Developments
  • 11.7 Cipla
    • 11.7.1 Cipla Company Information
    • 11.7.2 Cipla Semi-Solid Formulations Drug Delivery Product Offered
    • 11.7.3 Cipla Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Cipla Main Business Overview
    • 11.7.5 Cipla Latest Developments
  • 11.8 Bayer
    • 11.8.1 Bayer Company Information
    • 11.8.2 Bayer Semi-Solid Formulations Drug Delivery Product Offered
    • 11.8.3 Bayer Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Bayer Main Business Overview
    • 11.8.5 Bayer Latest Developments
  • 11.9 Viatris
    • 11.9.1 Viatris Company Information
    • 11.9.2 Viatris Semi-Solid Formulations Drug Delivery Product Offered
    • 11.9.3 Viatris Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Viatris Main Business Overview
    • 11.9.5 Viatris Latest Developments
  • 11.10 3M
    • 11.10.1 3M Company Information
    • 11.10.2 3M Semi-Solid Formulations Drug Delivery Product Offered
    • 11.10.3 3M Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 3M Main Business Overview
    • 11.10.5 3M Latest Developments
  • 11.11 Merck & Co
    • 11.11.1 Merck & Co Company Information
    • 11.11.2 Merck & Co Semi-Solid Formulations Drug Delivery Product Offered
    • 11.11.3 Merck & Co Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Merck & Co Main Business Overview
    • 11.11.5 Merck & Co Latest Developments
  • 11.12 Crescita Therpeautics
    • 11.12.1 Crescita Therpeautics Company Information
    • 11.12.2 Crescita Therpeautics Semi-Solid Formulations Drug Delivery Product Offered
    • 11.12.3 Crescita Therpeautics Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Crescita Therpeautics Main Business Overview
    • 11.12.5 Crescita Therpeautics Latest Developments
  • 11.13 Novartis International
    • 11.13.1 Novartis International Company Information
    • 11.13.2 Novartis International Semi-Solid Formulations Drug Delivery Product Offered
    • 11.13.3 Novartis International Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 Novartis International Main Business Overview
    • 11.13.5 Novartis International Latest Developments
  • 11.14 Boehringer Ingelheim
    • 11.14.1 Boehringer Ingelheim Company Information
    • 11.14.2 Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Product Offered
    • 11.14.3 Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 Boehringer Ingelheim Main Business Overview
    • 11.14.5 Boehringer Ingelheim Latest Developments
  • 11.15 Pfizer
    • 11.15.1 Pfizer Company Information
    • 11.15.2 Pfizer Semi-Solid Formulations Drug Delivery Product Offered
    • 11.15.3 Pfizer Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.15.4 Pfizer Main Business Overview
    • 11.15.5 Pfizer Latest Developments
  • 11.16 Teva Pharmaceuticals
    • 11.16.1 Teva Pharmaceuticals Company Information
    • 11.16.2 Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Product Offered
    • 11.16.3 Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.16.4 Teva Pharmaceuticals Main Business Overview
    • 11.16.5 Teva Pharmaceuticals Latest Developments
  • 11.17 Bristol Myers Squibb
    • 11.17.1 Bristol Myers Squibb Company Information
    • 11.17.2 Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Product Offered
    • 11.17.3 Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.17.4 Bristol Myers Squibb Main Business Overview
    • 11.17.5 Bristol Myers Squibb Latest Developments
  • 11.18 Lead Chemical
    • 11.18.1 Lead Chemical Company Information
    • 11.18.2 Lead Chemical Semi-Solid Formulations Drug Delivery Product Offered
    • 11.18.3 Lead Chemical Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.18.4 Lead Chemical Main Business Overview
    • 11.18.5 Lead Chemical Latest Developments
  • 11.19 Purdue Pharma
    • 11.19.1 Purdue Pharma Company Information
    • 11.19.2 Purdue Pharma Semi-Solid Formulations Drug Delivery Product Offered
    • 11.19.3 Purdue Pharma Semi-Solid Formulations Drug Delivery Revenue, Gross Margin and Market Share (2020-2022)
    • 11.19.4 Purdue Pharma Main Business Overview
    • 11.19.5 Purdue Pharma Latest Developments

12 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Semi-Solid Formulations Drug Delivery will have significant change from previous year. According to our (LP Information) latest study, the global Semi-Solid Formulations Drug Delivery market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Semi-Solid Formulations Drug Delivery market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Semi-Solid Formulations Drug Delivery market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Semi-Solid Formulations Drug Delivery market, reaching US$ million by the year 2028. As for the Europe Semi-Solid Formulations Drug Delivery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Semi-Solid Formulations Drug Delivery players cover Glenmark Pharmaceuticals, Galderma, Johnson & Johnson Private, and GlaxoSmithKline, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Semi-Solid Formulations Drug Delivery market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Creams
Ointments
Lotions
Gel
Pastes

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Home Care Settings
Hospitals & Clinics
Burn Centers
Other Facilities

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline
Bausch Health Companies
Hisamitsu Pharmaceuticals
Cipla
Bayer
Viatris
3M
Merck & Co
Crescita Therpeautics
Novartis International
Boehringer Ingelheim
Pfizer
Teva Pharmaceuticals
Bristol Myers Squibb
Lead Chemical
Purdue Pharma
Buy now